AFFIMED N V's ticker is AFMD and the CUSIP is N01045108. A total of 98 filers reported holding AFFIMED N V in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361,292 | -28.2% | 756,000 | -10.2% | 0.00% | 0.0% |
| Q2 2023 | $503,426 | -25.0% | 841,568 | -6.6% | 0.00% | -50.0% |
| Q1 2023 | $671,575 | -35.8% | 900,718 | +6.8% | 0.00% | -33.3% |
| Q4 2022 | $1,046,264 | +68.2% | 843,761 | +179.2% | 0.00% | +50.0% |
| Q3 2022 | $622,000 | -26.0% | 302,155 | -0.3% | 0.00% | -33.3% |
| Q2 2022 | $840,000 | -71.4% | 303,213 | -36.3% | 0.00% | -57.1% |
| Q3 2021 | $2,942,000 | -71.7% | 476,084 | -61.0% | 0.01% | -70.8% |
| Q2 2021 | $10,378,000 | +18.9% | 1,220,910 | +10.6% | 0.02% | +4.3% |
| Q1 2021 | $8,729,000 | +49.0% | 1,103,552 | +9.7% | 0.02% | +35.3% |
| Q4 2020 | $5,857,000 | +264.9% | 1,006,373 | +112.6% | 0.02% | +183.3% |
| Q3 2020 | $1,605,000 | +505.7% | 473,328 | +724.9% | 0.01% | +500.0% |
| Q2 2020 | $265,000 | +132.5% | 57,382 | -20.4% | 0.00% | 0.0% |
| Q1 2020 | $114,000 | -43.3% | 72,108 | -1.8% | 0.00% | 0.0% |
| Q4 2019 | $201,000 | +73.3% | 73,430 | +82.0% | 0.00% | – |
| Q2 2019 | $116,000 | – | 40,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Public Equity Management, LLC | 3,209,013 | $6,578,000 | 0.40% |
| Telemetry Investments, L.L.C. | 367,067 | $752,000 | 0.35% |
| NEA Management Company, LLC | 3,888,888 | $7,972,000 | 0.29% |
| DAFNA Capital Management LLC | 92,500 | $190,000 | 0.14% |
| Tekla Capital Management LLC | 1,405,324 | $2,881,000 | 0.11% |
| Perceptive Advisors | 668,214 | $1,369,000 | 0.07% |
| MUHLENKAMP & CO INC | 72,786 | $149,000 | 0.05% |
| Orbimed Advisors | 1,799,700 | $3,689,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $513,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $820,000 | 0.01% |